Chronic obstructive pulmonary disease (COPD) is currently a leading cause of death
worldwide, and its burden is expected to rise in the coming years. Common COPD …

Chronic obstructive pulmonary disease (COPD) imposes a substantial burden on individuals
with the disease, which can include a range of symptoms (breathlessness, cough, sputum …

This Executive Summary of the Global Strategy for the Diagnosis, Management, and
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …

Background The efficacy and safety of benralizumab, an interleukin-5 receptor alpha–
directed cytolytic monoclonal antibody, for the prevention of exacerbations in patients with …

Dyspnea refers to the sensation of breathlessness, shortness of breath, or difficulty breathing
that is commonly observed in patients with respiratory and cardiac disease. In the United …

Este resumen ejecutivo del Informe de 2017 de la Global Strategy for the Diagnosis,
Management, and Prevention of COPD (GOLD) se basa principalmente en las …

An individual's experience of COPD is determined by many factors in addition to the
pathological features of chronic bronchitis and emphysema and the symptoms that derive …

Conventional pulmonary rehabilitation programs are used as therapies for the treatment of
chronic obstructive pulmonary disease (COPD). However, this modality presents barriers …

Introduction The impact of asthma and chronic obstructive pulmonary disease (COPD) on
individuals' lives may be substantial, yet clinical practice often focuses only on symptoms …

Circadian clocks regulate the daily timing of many of our physiological, metabolic and
biochemical functions. The immune system also displays circadian oscillations in immune …